Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Geovax Labs
(NQ:
GOVX
)
6.390
-0.930 (-12.70%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Geovax Labs
< Previous
1
2
3
4
5
6
Next >
BioMedNewsBreaks — GeoVax Labs Inc. (NASDAQ: GOVX) Enters $8.5M Registered Direct Offering with Institutional Investor
August 21, 2024
Via
Investor Brand Network
Exposures
COVID-19
Registration is Now Open for Tribe Public's Webinar Event "Now Is Not the Time to Monkey(pox) Around" Featuring GeoVax Labs CEO
August 21, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
GeoVax Labs: Is This Micro-Cap Biotech Stock a Boom or a Bust?
August 20, 2024
GeoVax Labs has seen its shares rise enormously over the past few days after an announcement from the World Health Organization relevant to one of its drugs.
Via
MarketBeat
Exposures
COVID-19
GeoVax to Raise Approximately $8.5 Million of Gross Proceeds in Offering Priced Above-the-Market
August 20, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
GeoVax Provides First Half 2024 Business Update
July 09, 2024
Via
NewMediaWire
GeoVax to Present at BIO International Convention 2024
May 29, 2024
Via
TheNewswire.com
Exposures
COVID-19
GeoVax to Present Data on GEO-CM04S1, A Next Generation Covid-19 Vaccine, at the World Vaccine Congress
March 28, 2024
Via
NewMediaWire
Exposures
COVID-19
GeoVax to Present at the Emerging Growth Conference on August 21, 2024
August 15, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
COVID-19
GeoVax Appoints Teresa Lambe, Acclaimed Professor of Vaccinology and Immunology at the Oxford Vaccine Group, to Its Scientific Advisory Board
August 08, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
COVID-19
GeoVax Reports Second Quarter 2024 Financial Results and Provides Business Update
August 06, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
COVID-19
Update: GeoVax Announces Phase 2 Plans for Gedeptin Cancer Therapy Following Clinical Advisory Committee Review
July 31, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
GeoVax Announces Phase 2 Plans for Gedeptin Cancer Therapy Following Clinical Advisory Committee Review
July 31, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
GeoVax to Report Second Quarter 2024 Financial Results and Provide Corporate Update on August 6, 2024
July 30, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
GeoVax to Present at the Emerging Growth Conference on July 18, 2024
July 16, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
COVID-19
GeoVax to Present at the Emerging Growth Conference on July 18, 2024
July 16, 2024
Company to Discuss Recent BARDA Project NextGen Award for Its Next-generation COVID-19 Vaccine and Provide Progress Update Across Its Clinical Development Pipeline
Via
TheNewswire.com
Exposures
COVID-19
GeoVax to Raise Approximately $3.1 Million of Gross Proceeds in Offering Priced At-the-Market
July 11, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
GeoVax to Raise Approximately $3.1 Million of Gross Proceeds in Offering Priced At-the-Market
July 11, 2024
ATLANTA, GA - (NewMediaWire) - July 11, 2024 - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancer and infectious diseases,...
Via
TheNewswire.com
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
GeoVax Partners with Allucent to Conduct Phase 2b Clinical Study of Next-Generation COVID-19 Vaccine Candidate with Funding from BARDA
June 27, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
COVID-19
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth
June 20, 2024
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GOVX),(NYSE:GSK),(NASDAQ:AZN),(NYSE:MRK) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Death
Exposures
Death
GeoVax Receives BARDA Project NextGen Award to Conduct Phase 2b Clinical Study Evaluating the Company's Next-Generation COVID-19 Vaccine Candidate, GEO-CM04S1
June 18, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
COVID-19
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth
June 20, 2024
From
FN Media Group LLC
Via
GlobeNewswire
GeoVax to Present at BIO International Convention 2024
May 29, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
COVID-19
GeoVax to Raise Approximately $1.3 Million of Gross Proceeds in Offering Priced At-the-Market
May 17, 2024
ATLANTA, GA - (NewMediaWire) - May 17, 2024 - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancer and infectious diseases,...
Via
TheNewswire.com
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
GeoVax to Raise Approximately $1.3 Million of Gross Proceeds in Offering Priced At-the-Market
May 17, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
GeoVax Reports First Quarter 2024 Financial Results and Provides Business Update
May 14, 2024
Presented data on GEO-CM04S1 at World Vaccine Congress, delineating the unique immune system driven mechanisms that contribute to the broad efficacy of the vaccine candidate
Via
TheNewswire.com
GeoVax Reports First Quarter 2024 Financial Results and Provides Business Update
May 14, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
GeoVax to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024
May 07, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
GeoVax to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024
May 07, 2024
GeoVax to Host Conference Call at 4:30 PM ET
Via
TheNewswire.com
GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine
April 04, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
COVID-19
GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine
April 04, 2024
Presentation Made During the 24th Annual World Vaccine Congress
Via
TheNewswire.com
Exposures
COVID-19
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.